Fig. 1

An overall scheme of the study. T2DM, type 2 diabetes mellitus; CHIP, clonal hematopoiesis of indeterminate potential; VAF, Variant allele fraction; SNP, single nucleotide polymorphisms
An overall scheme of the study. T2DM, type 2 diabetes mellitus; CHIP, clonal hematopoiesis of indeterminate potential; VAF, Variant allele fraction; SNP, single nucleotide polymorphisms